Martin Shkreli (Dennis Van Tine/Sipa USA, Sipa via AP Images)

Scoop: Ac­tivist­s' at­tempt to take over in­fa­mous Mar­tin Shkre­li com­pa­ny fails, as ‘Phar­ma Bro’ votes from prison

An ac­tivist group’s ef­forts to gain con­trol of Phoenixus — the par­ent com­pa­ny to Mar­tin Shkre­li’s in­fa­mous Tur­ing Phar­ma­ceu­ti­cals, now ren­named as Vy­era — failed on Mon­day, as share­hold­ers vot­ed to keep four of the five cur­rent di­rec­tors. The vote was in­flu­enced by the “Phar­ma Bro” him­self, who vot­ed on his shares from prison.

The di­rec­tors — Miguel Bar­ron, William Rueck­ert, Jor­dan Walk­er and William Hess — were re-elect­ed in a land­slide vote, with many of them get­ting more than 70% of the votes in fa­vor. How­ev­er, share­hold­ers vot­ed over­whelm­ing­ly against re-elect­ing Aver­ill Pow­ers, CEO and chair­man.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.